Dr. Lorraine Nolan:

It is a very good question. CBD itself is what we could consider a "borderline product". It is contained in cosmetics, foods, food supplements and in medicines. The products in the shops, to which Deputy Crowe referred, are classified as foods and they should not be making any medicinal claims. Certainly, because they are not qualified healthcare professionals, anyone working in those shops should not be giving any advice in relation to whether these products can control pain. They are not meant to do that at all.

CBD is listed by the European Commission as what is called a "novel food". Those products have a different concentration of the CBD in them. Epidiolex, for example, is a 10% weight by volume product. Those products can have up to more or less a maximum of 3% and below that of CBD in them. It is part of our market surveillance programme and it is an area in which we are very active. I will pass over to Ms Farrell because it is her team within the authority that would look over that programme. We have taken action on those products when we found them in shops and found them to have made claims.